GSK

GSK Ups Forecast Following Strong Q2 Performance

GSK Ups Forecast Following Strong Q2 Performance

July 31, 2024

GSK Stock Fell After 40 Years of Silence Regarding Zantac’s Cancer Dangers, Bloomberg

GSK Stock Fell After 40 Years of Silence Regarding Zantac’s Cancer Dangers, Bloomberg

February 16, 2023

SpringWorks Increases License Agreement With GSK for Myeloma Combination and Receives $75 Million in Investment

SpringWorks Increases License Agreement With GSK for Myeloma Combination and Receives $75 Million in Investment

September 7, 2022